Chemomab Therapeutics (CMMB) Assets (2017 - 2026)
Chemomab Therapeutics' Assets came in at $10.24 million for Q2 2026, down 8.0% from $11.13 million a year earlier and down 13.3% from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Chemomab Therapeutics' Assets was $13.81 million, down 18.6% from FY2024.
- Assets has declined in each of the last four years, though with a five-year compound annual growth rate of 2.1% (FY2020 to FY2025).
- Going back by year, Assets was $16.96 million in FY2024 (-23.4%), $22.15 million in FY2023 (-48.6%), $43.06 million in FY2022 (-33.1%) and $64.35 million in FY2021 (+415.8%).
- The Q2 2026 figure represents the lowest quarterly Assets since Q3 2020.
- Year-over-year, Assets has declined for 17 consecutive quarters, with an average decline of 20.2% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q3 2021 (growth of 777.1%), and the weakest in Q3 2023 (a decline of 53.4%).
- Business Quant data shows CMMB's Assets at $11.81 million (Q1 2026), $13.81 million (Q4 2025) and $12.37 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Chemomab Therapeutics | 11.80 Mn | 11.80 Mn | - | 10.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.24 Mn |
| Mar 31, 2026 | 11.81 Mn |
| Dec 31, 2025 | 13.81 Mn |
| Sep 30, 2025 | 12.37 Mn |
| Jun 30, 2025 | 11.13 Mn |
| Mar 31, 2025 | 12.82 Mn |
| Dec 31, 2024 | 16.96 Mn |
| Sep 30, 2024 | 20.90 Mn |
| Jun 30, 2024 | 14.54 Mn |
| Mar 31, 2024 | 18.01 Mn |
| Dec 31, 2023 | 22.15 Mn |
| Sep 30, 2023 | 23.42 Mn |
| Jun 30, 2023 | 28.85 Mn |
| Mar 31, 2023 | 35.01 Mn |
| Dec 31, 2022 | 43.06 Mn |
| Sep 30, 2022 | 50.22 Mn |
| Jun 30, 2022 | 56.38 Mn |
| Mar 31, 2022 | 60.96 Mn |
| Dec 31, 2021 | 64.35 Mn |
| Sep 30, 2021 | 67.44 Mn |
API Access
Chemomab Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();